Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-06

FDA Approved: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

The FDA approved Teva Respiratory's supplemental application for QVAR REDIHALER (beclomethasone dipropionate HFA). The action pertains to a supplement for this …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QVAR REDIHALER (Beclomethasone dipropionate HFA)

Snippet

SUPPL AP for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)